Accel Pharma is a leading pharmaceutical research and development firm specialized on creating breakthrough therapies for underserved chronic illnesses with limited existing treatment options. Founded in 2010, the company has swiftly grown its footprint across 25 countries, with global headquarters in Boston, London, and Singapore. Its core mission is to speed up the rollout of life-changing treatments to patients who have been excluded from effective care for their conditions.